(Q35587582)

9 August 2017

title

The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer (English)

1 reference

9 August 2017

1 reference

1 reference

1 reference

L Nakopoulou

1

1 reference

9 August 2017

A C Lazaris

2

1 reference

9 August 2017

E G Panayotopoulou

3

1 reference

9 August 2017

I Giannopoulou

4

1 reference

9 August 2017

N Givalos

5

1 reference

9 August 2017

S Markaki

6

1 reference

9 August 2017

A Keramopoulos

7

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

Journal of Clinical Pathology

9 August 2017

published in

1 reference

9 August 2017

volume

57

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

523-528

1 reference

Oestrogen receptor beta in breast cancer: good, bad or still too early to tell?

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Distinct expression patterns of ER alpha and ER beta in normal human mammary gland

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Expression of oestrogen receptor beta (ERbeta1) protein in human breast cancer biopsies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

ER beta inhibits proliferation and invasion of breast cancer cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Immunohistochemical detection of ERbeta in breast cancer: towards more detailed receptor profiling?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Predictive value of topoisomerase II alpha immunostaining in urothelial bladder carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Estrogen receptor beta expression in invasive breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Clinical value of the wild-type estrogen receptor beta expression in breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Steroid hormone receptors in breast cancer management

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Histological grading of breast carcinomas: a study of interobserver agreement.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Estrogen receptor beta in breast cancer.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Clinicopathological characteristics of estrogen receptor-beta-positive human breast cancers

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

Estrogen receptors alpha and beta in the rodent mammary gland

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770285

bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining

26 September 2018

1 reference

12 December 2020

Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications

1 reference

12 December 2020

Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer

1 reference

12 December 2020

A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer

1 reference

12 December 2020

DNA topoisomerase II-alpha immunoreactivity as a marker of tumor aggressiveness in invasive breast cancer

1 reference

12 December 2020

Use of the monoclonal antibody DAKO-ERbeta (8D5-1) to measure oestrogen receptor beta in breast cancer cells

1 reference

12 December 2020

The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells

1 reference

12 December 2020

The international histological classification of tumours

1 reference

12 December 2020

Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer

1 reference

12 December 2020

Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer?

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.2003.008599

1 reference

9 August 2017

1 reference

9 August 2017

1 reference